Total Payments
$15,586
2024 Payments
$1,363
Companies
49
Transactions
1,068
Medicare Patients
19,058
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$15,400 (98.8%)
Education$171.36 (1.1%)
Other$14.63 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,400 | 1,047 | 98.8% |
| Education | $171.36 | 20 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.63 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,591 | 112 | $0 (2024) |
| Lilly USA, LLC | $1,470 | 123 | $0 (2024) |
| PFIZER INC. | $1,406 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,248 | 83 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,186 | 79 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,180 | 66 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $676.97 | 54 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $669.42 | 42 | $0 (2023) |
| ABBVIE INC. | $646.50 | 53 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $566.56 | 31 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,363 | 90 | AstraZeneca Pharmaceuticals LP ($219.76) |
| 2023 | $1,786 | 110 | Lilly USA, LLC ($223.09) |
| 2022 | $2,151 | 143 | Janssen Pharmaceuticals, Inc ($244.94) |
| 2021 | $2,141 | 145 | AbbVie Inc. ($284.09) |
| 2020 | $1,823 | 118 | PFIZER INC. ($317.53) |
| 2019 | $2,253 | 173 | PFIZER INC. ($270.06) |
| 2018 | $1,981 | 136 | PFIZER INC. ($309.72) |
| 2017 | $2,087 | 153 | Novo Nordisk Inc ($434.79) |
All Payment Transactions
1,068 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Respiratory | ||||||
| 10/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Analgesic | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes Care | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $1.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,647 | 33,017 | $819,912 | $371,172 |
| 2022 | 44 | 4,155 | 36,214 | $822,821 | $389,149 |
| 2021 | 49 | 6,196 | 38,771 | $1.0M | $511,396 |
| 2020 | 48 | 5,060 | 47,246 | $1.1M | $461,183 |
Total Patients
19,058
Total Services
155,248
Medicare Billing
$1.7M
Procedure Codes
181
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 2,376 | $323,648 | $190,004 | 58.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 124 | 576 | $69,256 | $33,129 | 47.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 67 | 428 | $49,962 | $32,571 | 65.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 282 | 2,250 | $70,614 | $20,656 | 29.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 114 | 158 | $34,399 | $14,360 | 41.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 189 | 189 | $15,690 | $13,973 | 89.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 147 | 226 | $32,859 | $13,102 | 39.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 51 | 51 | $17,850 | $6,424 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 215 | 215 | $7,104 | $6,071 | 85.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 68 | 75 | $16,120 | $5,743 | 35.6% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 47 | 51 | $6,504 | $4,511 | 69.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 251 | 855 | $22,360 | $4,469 | 20.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 53 | 63 | $4,662 | $3,077 | 66.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 228 | 328 | $3,426 | $2,612 | 76.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 126 | 814 | $8,504 | $2,578 | 30.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 41 | 95 | $4,960 | $2,344 | 47.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 48 | 58 | $3,926 | $2,004 | 51.0% |
| 11308 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, more than 2.0 cm | Office | 2023 | 27 | 37 | $10,696 | $1,930 | 18.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 51 | 52 | $2,460 | $1,911 | 77.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 67 | 153 | $6,998 | $1,589 | 22.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 98 | 168 | $4,430 | $1,465 | 33.1% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 32 | 32 | $1,197 | $1,005 | 83.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 209 | 765 | $20,020 | $831.62 | 4.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 16 | $1,530 | $707.55 | 46.2% |
| 72120 | X-ray lower and sacral spine, 2-3 views bending views | Office | 2023 | 17 | 37 | $3,495 | $515.48 | 14.7% |
About Dr. Mark Roberts, MD
Dr. Mark Roberts, MD is a Hospice and Palliative Medicine healthcare provider based in Evergreen, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275565442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Roberts, MD has received a total of $15,586 in payments from pharmaceutical and medical device companies, with $1,363 received in 2024. These payments were reported across 1,068 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($15,400).
As a Medicare-enrolled provider, Roberts has provided services to 19,058 Medicare beneficiaries, totaling 155,248 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Pain Medicine, Family Medicine
- Location Evergreen, AL
- Active Since 07/07/2006
- Last Updated 06/13/2022
- Taxonomy Code 207QH0002X
- Entity Type Individual
- NPI Number 1275565442
Products in Payments
- XARELTO (Drug) $980.98
- Ozempic (Drug) $928.04
- FARXIGA (Drug) $833.75
- TRELEGY ELLIPTA (Drug) $775.45
- TRULICITY (Drug) $674.98
- JARDIANCE (Drug) $576.21
- Vascepa (Drug) $540.85
- VRAYLAR (Drug) $477.61
- ELIQUIS (Drug) $446.57
- Victoza (Drug) $444.82
- TRINTELLIX (Drug) $405.90
- Kerendia (Drug) $391.98
- SOLIQUA 100/33 (Biological) $364.01
- LINZESS (Drug) $350.75
- MOUNJARO (Drug) $317.27
- ZTLido (Drug) $314.40
- CHANTIX (Drug) $248.28
- INVOKANA (Drug) $243.28
- Dexcom G6 Transmitter (Medical Supply) $200.84
- EUCRISA (Drug) $190.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.